Kyprolis is primarily prescribed for patients with multiple myeloma who have received at least one prior therapy. It can be used alone or in combination with other drugs like lenalidomide and dexamethasone. Patients who have not responded to other treatments may find Kyprolis to be an effective option. However, it is essential for healthcare providers to evaluate each patient's unique case to determine the appropriateness of this treatment.
